← Product Code [GEI](/submissions/SU/subpart-e%E2%80%94surgical-devices/GEI) · K130110 # MEDDUSA BIPOLAR SYSTEM (K130110) _Elliquence, LLC · GEI · Oct 8, 2013 · General, Plastic Surgery · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEI/K130110 ## Device Facts - **Applicant:** Elliquence, LLC - **Product Code:** [GEI](/submissions/SU/subpart-e%E2%80%94surgical-devices/GEI.md) - **Decision Date:** Oct 8, 2013 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 878.4400 - **Device Class:** Class 2 - **Review Panel:** General, Plastic Surgery - **Attributes:** Therapeutic ## Indications for Use The Meddusa Bipolar System is a single-use product designed for and intended to be used exclusively with Surgi-Max® RF Generators (510(k) K100390). For optimal performance the Surgi-Max® Plus generator (510(k) K100390) is recommended. The Meddusa™ Bipolar System is intended for use by a physician familiar with bipolar coagulation with electrosurgery where coagulation/contraction of soft tissue is needed. The types of surgery intended are: General surgery, Laparoscopic procedures, Endoscopic procedures, Laryngeal coagulation, Open abdominal, Orthopedic coagulation, Thorascopic coagulation, Neurosurgical coagulation, Gynecological coagulation, (except for use in female sterilization), Ear, Nose, Throat coagulation. ## Device Story Meddusa Bipolar System is a disposable, sterile, surgically invasive electrosurgical device. It functions as an accessory to the Surgi-Max Plus RF generator (K100390). The generator delivers high-frequency, low-temperature radiowaves to the device tip, which transfers electrical energy to tissue at the surgical site to achieve cutting or coagulation. Used by physicians in various surgical settings (OR, endoscopic, etc.) for soft tissue coagulation/contraction. The device provides the physical interface for energy delivery; the physician controls the effect via generator settings. Benefits include controlled thermal tissue effects for hemostasis or tissue contraction. Construction includes stainless steel, ABS plastic, and TEFLON heat shrink tubing. ## Clinical Evidence Bench testing only. No clinical data provided. Testing included ex vivo tissue studies (liver, kidney, muscle) to compare thermal effect (width/depth of damage) and temperature profiles of electrode tips and cables against predicate devices under maximum power and duration settings. Biocompatibility and dielectric testing were also performed. ## Technological Characteristics Disposable, sterile, surgically invasive device. Materials: stainless steel, ABS plastic, TEFLON heat shrink tubing. Energy source: RF energy from external Surgi-Max generator. Contact duration: <24 hours (transient). Biocompatible per ISO 10993-1:2003. Connectivity: wired connection to RF generator. ## Regulatory Identification An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current. ## Predicate Devices - Bipolar Trigger-Flex Probe ([K003126](/device/K003126.md)) - Aquamantys 2.3 Bipolar Sealer ([K052859](/device/K052859.md)) - Disc-FX System ([K052241](/device/K052241.md)) ## Reference Devices - Surgi-Max Plus Radiofrequency generator ([K100390](/device/K100390.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K130110 Page 1 of 3 ## 510 (k) Summary (As Required By 21 CFR 807.92(a)) #### Date Prepared January 10, 2013 #### Submitter's Information Company Name and Address: Elliquence, LLC. 2455 Grand Avenue. Baldwin, NY 11510 Phone: (516) 277-9000 Fax: (516) 277-9001 www.elliquence.com OCT 0 8 2013 Establishment Registration for Elliquence, LLC is 3007024186. Contact Information: John Pikramenos - Product Development Director Phone: (516) 277-9012 Fax: (516) 277-9025 Email: johnp@elliquence.com Paul Buhrke - Product Development Manager Phone: (516) 277-9010 Fax: (516) 277-9011 Email: pbuhrke@elliquence.com #### Trade Name Device Trade Name is Meddusa Bipolar System #### Device Common, Usual, or Classification Names Electrosurgical Cutting and Coagulation Device and Accessories. #### Classification Panel Classification of this device would fall under the responsibility of the Division of General, Restorative, and Neurological Devices. {1}------------------------------------------------ ## Class Classification: Class 2. Product Code: GEI, 21 CFR 878.4400 ## Predicate Device - Bipolar Trigger-Flex Probe (510(k) K003126) . - Aquamantys 2.3 Bipolar Sealer (510(k) K052859) . - . Disc-FX System (510(k) K052241) ### Description of the Device The Meddusa Bipolar System is a disposable device manufacturer of medical grade Stainless Steel, ABS plastic and TEFLON heat shrink tubing. The category of contact as classified by ISO 10993-1:2003 are that the device is an (1) External Communicating Device, (2) Contact Area: Tissue, Bone, Dentin, (3) Contact Duration <24 hrs. The Meddusa Bipolar System is classified as Sterile, Surgically Invasive, Active Device, with intended patient contact for a period for <1hr (Transient). The Meddusa Bipolar System is intended to be used with the elliguence Surgi-Max Plus Radiofrequency generator (510(k) K100390). The Surgi-Max emits high frequency, lowtemperature radiowaves which is directed to the Meddusa Bipolar System tip. The electrical power operating at radio frequency (RF) is transferred to tissue at the surgical site. The timevarying voltage produced by the electrical power source vields a predetermined electrosurgical effect, such as tissue cutting or coagulation. ### Intended Use The Meddusa Bipolar System is a single-use product designed for and intended to be used exclusively with Surgi-Max® RF Generators (510(k) K100390). For optimal performance the Surgi-Max® Plus generator (510(k) K100390) is recommended. The Meddusa™ Bipolar System is intended for use by a physician familiar with bipolar coagulation with electrosurgery where coagulation/contraction of soft tissue is needed. The types of surgery intended are: General surgery, Laparoscopic procedures, Endoscopic procedures, Laryngeal coagulation, Open abdominal. Orthopedic coaqulation. Thorascopic coagulation, Neurosurgical coaqulation, Gynecological coagulation, (except for use in female sterilization), Ear, Nose, Throat coagulation. ### Technological Characteristics {2}------------------------------------------------ The device is substantially equivalent to the predicate device based on a comparison on physical and performance characteristics. ### Performance Data The subject device is composed of biocompatible materials, has passed dielectric testing, and performs similarly to the predicate devices. Bench tests used ex vivo tissue that included liver, kidney, and muscle tissue. The subject device and predicate devices were compared to demonstrate the thermal effect on tissue by measuring the width and depth of the thermally damaged zones in relation to tissue type, intensity setting, and duration of activation. The temperature profile of the subject device applicator and cable was recorded during simulation use for the maximum energy delivery duration at the maximum power to demonstrate the maximum applicator surface area and maximum cable surface temperature will be safe to the user and/or to the patient. The peak temperatures of the electrode tips and target tissue/vessels when the device is used for the maximum recommended duration and generator output settings was compared. Based on the results of the various bench tests, it was determined that the subject device is safe and effective. #### Conclusion We conclude that the subject device is safe and effective as the predicate device. {3}------------------------------------------------ Image /page/3/Picture/0 description: The image shows the logo for the Department of Health & Human Services USA. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is an abstract image of an eagle. #### DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center -- WO66-G604 Silver Spring, MD 20993-0002 Elliquence Innovative Medical Solutions Mr. John Pikramenos Product Development Director 2455 Grand Avenue Baldwin, New York 11510 Re: K130110 Trade/Device Name: Meddusa Bipolar System Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: Class II Product Code: GEI Dated: September 13, 2013 Received: September 17, 2013 Dear Mr. Pikramenos: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or 10 devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH docs not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act 's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set October 8, 2013 {4}------------------------------------------------ Page 2 - Mr. John Pikramenos forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours, # Mark N. Melkerson -S Mark N. Melkerson Acting Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ ## Indications for Use 510(k) Number (if known): K130110 Device Name: Meddusa Bipolar System. Indications For Use: The Meddusa Bipolar System is a single-use product designed for and intended to be used exclusively with Surgi-Max® RF Generators (510(k) K100390). For optimal performance the Surgi-Max® Plus generator (510(k) K100390) is recommended. The Meddusa™ Bipolar System is intended for use by a physician familiar with bipolar coagulation with electrosurgery where coagulation/contraction of soft tissue is needed. The types of surgery intended are: General surgery, Laparoscopic procedures, Endoscopic procedures, Laryngeal coagulation, Open abdominal, Orthopedic coagulation, Thorascopic coagulation, Neurosurgical coagulation, Gynecological coagulation, (except for use in female sterilization), Ear, Nose, Throat coagulation. Prescription Use (Part 21 CFR 801 Subpart D) ✓ AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Long H. Chen -A 342.19200300.100.1.1 = 1 1003499056 for MXM (Division Sign-off) Division of Surgical Devices 510(k) Number K130110 --- **Source:** [https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEI/K130110](https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEI/K130110) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com